Skip to main content
. 2022 Feb 25;12(3):352. doi: 10.3390/jpm12030352

Figure 1.

Figure 1

Mortality of β-Thalassemia heterozygotes from COVID-19: distribution of SARS-CoV-2 infected β-Thalassemia trait carriers (red box) among study participants who died (Yes), or survived (No) from COVID-19, relative to non-carriers (blue box).